We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Cytomyx Hldgs | LSE:CYX | London | Ordinary Share | GB0033942276 | ORD 2.5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.10 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:5093O
Cytomyx Holdings PLC
22 December 2006
Cytomyx Holdings plc (the 'Company')
The Company has today made application for 2,000,000 ordinary share to be
admitted to trading on AIM.
The ordinary shares were issued as a result of deferred consideration payable to
Aptus Pharmaceuticals and a payment in lieu of fees, but due to an
administrative error have not yet been admitted to trading on AIM. Admission is
expected to occur on 29 December 2006.
As a result of this admission the issued share capital of the Company has not
changed and remains at 63,608,256 ordinary shares.
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEAKDKPABDDABB
1 Year Cytomyx Chart |
1 Month Cytomyx Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
